Cerus
CERS
#7563
Rank
NZ$0.67 B
Marketcap
NZ$3.54
Share price
0.00%
Change (1 day)
20.45%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -NZ$12.43 Million

According to Cerus's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2024 the company made an earning of -NZ$20.41 Million, an increase over its 2023 earnings that were of -NZ$49.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$12.43 Million-39.11%
2024 -NZ$20.41 Million-58.95%
2023 -NZ$49.71 Million-20.74%
2022 -NZ$62.71 Million-25.7%
2021 -NZ$84.4 Million-11.99%
2020 -NZ$95.9 Million-14%
2019 -NZ$0.12 Billion21.73%
2018 -NZ$91.6 Million-0.65%
2017 -NZ$92.2 Million-10.96%
2016 -NZ$0.11 Billion4.24%
2015 -NZ$99.35 Million50.99%
2014 -NZ$65.8 Million-10.08%
2013 -NZ$73.18 Million184.13%
2012 -NZ$25.76 Million-7.91%
2011 -NZ$27.97 Million
2009 -NZ$39.5 Million-24.69%
2008 -NZ$52.45 Million-25.2%
2007 -NZ$70.11 Million330.54%
2006 -NZ$16.29 Million1.49%
2005 -NZ$16.05 Million-61.02%
2004 -NZ$41.17 Million
2002 -NZ$0.11 Billion10.02%
2001 -NZ$92.55 Million34.25%
2000 -NZ$68.94 Million61.02%
1999 -NZ$42.82 Million-18.81%
1998 -NZ$52.74 Million93.08%
1997 -NZ$27.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Haemonetics
HAE
NZ$0.41 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$16.3 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$5.61 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
NZ$25.1 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA